CASI Pharmaceuticals Inc. (CASI)
(Delayed Data from NSDQ)
$1.52 USD
-0.15 (-8.98%)
Updated Sep 23, 2025 04:00 PM ET
After-Market: $1.58 +0.06 (3.95%) 5:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, CASI Pharmaceuticals Inc. has a market cap of $20.54M, which represents its share price of $1.67 multiplied by its outstanding shares number of 12.30M. As a small-cap company, CASI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CASI 1.52 -0.15(-8.98%)
Will CASI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CASI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CASI
Veeva Systems (VEEV) Surpasses Q2 Earnings and Revenue Estimates
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
CASI: What are Zacks experts saying now?
Zacks Private Portfolio Services
VAXART, INC. (VXRT) Reports Q2 Loss, Beats Revenue Estimates
Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates
Other News for CASI
CASI forms Lower Bollinger Band Walk on September 22
CASI forms MACD Bearish Centerline Cross on September 19
Fell Below 50 Day Moving Average appears for CASI after 6.56% move
CASI forms Lower Bollinger Band Walk on September 17
Is CASI gathering momentum? Narrow Range Bar shows up after sliding 3.83%